Ocugen (OCGN) Return on Capital Employed Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -10,850.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,850.00 |
| Dec 31, 2025 | -12,252.00 |
| Sep 30, 2025 | -8,822.00 |
| Jun 30, 2025 | -7,904.00 |
| Mar 31, 2025 | -3,746.00 |
| Dec 31, 2024 | -5,244.00 |
| Sep 30, 2024 | -10,638.00 |
| Jun 30, 2024 | -12,767.00 |
| Mar 31, 2024 | -7,457.00 |
| Dec 31, 2023 | -2,013.00 |
| Sep 30, 2023 | -383.00 |
| Jun 30, 2023 | -219.00 |
| Mar 31, 2023 | 177.00 |
| Dec 31, 2022 | -1,577.00 |
| Sep 30, 2022 | -15,217.00 |
| Jun 30, 2022 | 12,958.00 |
| Mar 31, 2022 | 25,608.00 |
| Dec 31, 2021 | -34,429.00 |
| Sep 30, 2021 | 49,415.00 |
| Jun 30, 2021 | 32,634.00 |
| Mar 31, 2021 | 24,483.00 |
| Dec 31, 2020 | 15,455.00 |
| Sep 30, 2020 | 4,623.00 |
| Jun 30, 2020 | -19.00 |
| Mar 31, 2020 | -1,416.00 |
| Dec 31, 2019 | -194.00 |
| Sep 30, 2019 | 19,449.00 |
| Jun 30, 2019 | -886.00 |
| Mar 31, 2019 | -20,046.00 |
| Dec 31, 2018 | 38,025.00 |
| Sep 30, 2018 | -46,503.00 |
| Jun 30, 2018 | -30,891.00 |
| Mar 31, 2018 | -24,892.00 |